Navigation Links
First Aid Supplier HART Health Acquires Competitor and Continues Expansion
Date:9/2/2010

SEATTLE, Sept. 2 /PRNewswire/ -- HART Health, a national manufacturer and distributor of commercial first aid supplies, has acquired the van service division of Synergy Logistics, a Seattle-based first aid supply company. The acquisition follows HART's launch of a new franchise system.

Synergy Logistics, Inc. had been providing commercial first aid supplies through a van delivery service to mid-sized Seattle businesses since the early 1990's and was distributing HART Health first aid products. HART will fold Synergy customers into its existing Seattle van service.

"We're focused on expanding our first aid van delivery service and it makes sense for us to take over Synergy's van service," said Larry Shaw, HART Health CEO. "Synergy was already distributing our products and Synergy customers will now get a higher level of customer service and will benefit from our inventory management systems, which could lower their costs."

HART Health manufactures and distributes first aid supplies for the workplace. OSHA requires companies to provide necessary first aid supplies for their employees and most companies outsource management and supply of first aid kits. Outsourcing controls costs and helps companies stay in legal compliance with little effort.

HART Health manufactures its own products and its van service uses a proprietary handheld inventory tracking system that allows companies to easily track usage and monitor product levels.

"HART is a good choice to take over our van service," said Chris Westwood, Synergy Logistics CEO. "We are already a HART distributor and were supplying our customers with HART products. HART has an advanced system for delivery and inventory control and our customers will benefit from the new service."

HART Health launched a franchise system this year to expand its van service to companies outside the Pacific Northwest, where it is a well-known brand. The acquisition of Synergy Logistics' van service is one of a series of market expansions and new franchises HART expects to announce in the upcoming year.

"We're focused on developing the highest quality commercial first aid supplies on the market," said Shaw. "Companies are spending more on employee first aid supplies in the workplace because it is an inexpensive way to lower health care costs. Our customers are spending more on supplies in the recession even though they have reduced the number of employees; we believe the commercial first aid supply market is ripe for growth."

For information on HART Health, visit www.harthealth.com and www.harthealthfranchise.com.

Company Contact:

Larry Shaw, CEO, HART Health

1-800-234-4278

lshaw@harthealth.com


'/>"/>
SOURCE HART Health
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
2. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
3. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
4. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
5. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
6. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
7. Tainted Chinese Food Ingredients First Discovered in 2005
8. First Patient Enrolled in Europe in Ovature Phase III Ovarian Cancer Trial
9. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
10. Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule
11. Opko Health Doses First Patient in Phase 3 COBALT Trial of Bevasiranib for the Treatment of AMD
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... 2017  Drug diversion is a significant contributing ... overdoses. A new oral fluid monitoring test, announced ... reports more detailed and actionable information to clinicians ... therapy adherence, patient safety, and help to identify ... fluid Rx Evaluation (CORE) system is the first ...
(Date:3/23/2017)... - INVICTUS MD STRATEGIES CORP. ("Invictus MD" or the "Company") ... that AB Laboratories Inc. ("AB Labs") has successfully completed ... the Access to Cannabis for Medical Purposes Regulations ("ACMPR") ... The facility, which was licensed for Cultivation ... at half capacity, with full production capacity scheduled by ...
(Date:3/23/2017)... -- Piramal Pharma Solutions (PPS), una ... de Stuart E. Needleman como director ... completa para su base de clientes farmacéuticos global ... crecimiento y ejecución de las ofertas PPS. Como ... las actividades de desarrollo empresarial global para el ...
Breaking Medicine Technology:
(Date:3/23/2017)... , ... March 23, 2017 , ... ... families and businesses of the greater Fort Collins area, has unveiled a collaboration ... ongoing community involvement program. Donations to this worthy cause may now be made ...
(Date:3/23/2017)... (PRWEB) , ... March 23, 2017 , ... ?This conference will prominently feature 150+ Hospital ... President and Director, AMN Healthcare: Susan Salka , 43rd President of the United ... The Big Fight My Life In and Out of the Ring: Sugar Ray Leonard , ...
(Date:3/23/2017)... , ... March 23, 2017 , ... ... that help improve all aspects of people’s health and nutrition, announced its product ... products. , Natural Subsistence develops nutritional supplements that help people improve all ...
(Date:3/23/2017)... New Port Richey, FL (PRWEB) , ... March 23, 2017 , ... ... delighted to announce that 2017 marks the 40th Anniversary of ABQAURP’s dedication to Health ... that ABQAURP honors those who have contributed not only to the association, but also ...
(Date:3/23/2017)... (PRWEB) , ... March 23, ... ... Reports: Complying with European Guidelines and the New MEDDEV 2.7/1 Rev. 4 ... p.m. ET, http://www.fdanews.com/mdclineval                  , How will the new EU MDR ...
Breaking Medicine News(10 mins):